Outline title: «First live birth
using human oocytes reconstituted by spindle nuclear transfer for mitochondrial DNA mutation causing Leigh syndrome» by J. Zhang et al. published in outline form by the American Society of Reproductive Medicine's Fertility and Sterility journal website.
Not exact matches
Mindful of public sensitivities, Daley opted to pursue experiments
using what he considers the least controversial
human materials to create new nonpresidential stem cell lines — poor quality embryos and
oocytes that, in his words, «otherwise would have been disposed of as medical waste.»
To do this, they
used a nanotemplate of known stoichiometry (the
human Glycine receptor expressed in Xenopus
oocytes) and studied several fluorescent proteins to see the percentage of proteins that was photoactivated.
«The idea will be to obtain
oocytes and discarded embryos from IVF treatments in order to test this technology
using human samples.»
«The
use of nonhuman
oocytes for SCNT is currently the only ethically justifiable option given the large numbers of eggs required to derive cloned
human stem cell lines,» he said.
While many important developments impacted the field, two that garnered significant public, political and scientific attention in 2016 were the proliferation of clinics
using unproven stem cell «therapies,» and the steps forward in therapeutic modification of
human oocytes (unfertilized eggs) through a process called mitochondrial replacement therapy (MRT).
As outlined below, we
used a microfluidic quantitative PCR (qPCR) system to elucidate the gene expression profiles of individual
human oocytes and small numbers of cumulus cells
using a combination of a large number of samples and targets [12], and then extended our studies via the
use of parthenogenesis, in conjunction with gene expression profiling, as a functional assay of cytoplasmic maturation of
oocytes.
Ms. Roxland concurrently served as the Special Advisor to the Commissioner of Health on Stem Cell Research Ethics, where she spearheaded creation of state - wide rules on embryonic stem cell protocols,
human - animal chimera research, compensation of women who donate their
oocytes to stem cell research, informed consent processes, re-contact for return of research results and incidental findings, and downstream
uses of biological samples.